As of Oct 9, 2026 close
- Market cap
- $370.13M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $7.97$17.82
- Volume (live)
- -
- Avg. volume (3M)
- 182.76K
AgomAb Therapeutics NV (AGMB) Stock Price & Financial Analysis
AgomAb Therapeutics NV Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.92 - $9.49 |
|---|---|
| 52-Week High | $17.82 |
| 52-Week Low | $7.97 |
| Open | $9.36 |
| Volume (last close) | 102.31K |
| Average Volume (3M) | 182.76K |
| Market Cap | 370.13M |
|---|---|
| Shares Outstanding | 40.76M |
| Price to Book (P/B) | 1.26 |
| EV/EBITDA | -1.65 |
| 50-Day MA | $12.62 |
|---|
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
AgomAb Therapeutics NV at a Glance
AgomAb Therapeutics NV (AGMB) has a market capitalization of $370.13M.
It holds $248.76M in cash and securities against $1.02M of debt, a net cash position of $247.74M.
AgomAb Therapeutics NV does not currently pay a dividend.
At $9.08 it sits near the bottom of its 52-week range of $7.97 to $17.82.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $35.00, 285.5% above the latest close.
Frequently Asked Questions About AgomAb Therapeutics NV
What is the current stock price for AGMB?
As of the Oct 9, 2026 close, AGMB stock trades at $9.08. The 52-week range is $7.97–$17.82, with a day range of $8.92–$9.49.
What is the P/E ratio for AGMB?
The P/E ratio (Price-to-Earnings) for AGMB is shown in the Key Statistics section. This valuation metric helps compare AgomAb Therapeutics NV to industry peers.
Does AGMB pay dividends?
AgomAb Therapeutics NV does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for AGMB?
Based on 7 analysts, the consensus for AGMB is Buy.
What is the market cap of AGMB?
AgomAb Therapeutics NV's market capitalization is $370.1M, classifying it as a small-cap company. AgomAb Therapeutics NV operates in the Healthcare sector within the Biotechnology industry.